We are the global leader in commercial manufacturing of specific
and non-specific IgY antibodies.

As the global leader in IgY Technology, we are actively developing Biologics, Consumer Health, and Animal Health solutions to address a wide range of needs.  Our development process integrates our clinical and operational teams to identify top tier prospects that we believe will have the most impact in the marketplace. We then work through a methodical development process to ensure the safety, effectiveness, and scalability of solutions.

Our core technology makes commercial health applications of IgY possible.

Our multi‐stage proprietary process allows for the environmentally friendly production of specific and non-specific IgY antibodies from hen egg yolks at high purities, high volumes and at low unit costs. This encourages adoption of IgY for health applications across nutraceutical, pharmaceutical, and animal health markets.